×
ADVERTISEMENT

fremanezumab

FDA Approves Ajovy for Migraine Prevention

The FDA approved Ajovy, a humanized monoclonal antibody, for the prevention of migraine in adults. 

SEPTEMBER 18, 2018

Fremanezumab for Migraine Shows Impressive Results

Subcutaneous injections of the experimental migraine drug fremanezumab at monthly or quarterly intervals provided ...

NOVEMBER 27, 2017

Load more